{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:16:39Z","timestamp":1791252999709,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["No. 202040126"],"award-info":[{"award-number":["No. 202040126"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81971535"],"award-info":[{"award-number":["No. 81971535"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00406-024-01815-x","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T10:04:17Z","timestamp":1717149857000},"page":"1049-1061","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Unlocking the potential of the 3-hydroxykynurenine\/kynurenic acid ratio: a promising biomarker in adolescent major depressive disorder"],"prefix":"10.1007","volume":"275","author":[{"given":"Zhihan","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2763-8886","authenticated-orcid":false,"given":"Chuanyuan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"key":"1815_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41380-020-00930-0","volume":"26","author":"B Zhou","year":"2021","unstructured":"Zhou B, Zhu Z, Ransom BR, Tong X (2021) Oligodendrocyte lineage cells and depression. Mol Psychiatry 26:103\u2013117. https:\/\/doi.org\/10.1038\/s41380-020-00930-0","journal-title":"Mol Psychiatry"},{"issue":"10312","key":"1815_CR2","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","volume":"398","author":"DF Santomauro","year":"2021","unstructured":"Santomauro DF et al (2021) Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 398(10312):1700\u20131712. https:\/\/doi.org\/10.1016\/S0140-6736(21)02143-7","journal-title":"Lancet"},{"key":"1815_CR3","first-page":"188","volume-title":"Blue book of mental health: report on National Mental Health Development in China (2019\u20132020)","author":"XL Fu","year":"2021","unstructured":"Fu XL et al (2021) Blue book of mental health: report on National Mental Health Development in China (2019\u20132020). Social Sciences Academic Press, Beijing, pp 188\u2013203"},{"issue":"5","key":"1815_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00127-018-1496-z","volume":"53","author":"J Davies","year":"2018","unstructured":"Davies J, Sullivan S, Zammit S (2018) Adverse life outcomes associated with adolescent psychotic experiences and depressive symptoms. Soc Psychiatry Psychiatr Epidemiol 53(5):497\u2013507. https:\/\/doi.org\/10.1007\/s00127-018-1496-z","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"1815_CR5","doi-asserted-by":"publisher","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","volume":"2","author":"C Otte","year":"2016","unstructured":"Otte C et al (2016) Major depressive disorder. Nat Rev Dis Primers 2:16065. https:\/\/doi.org\/10.1038\/nrdp.2016.65","journal-title":"Nat Rev Dis Primers"},{"key":"1815_CR6","doi-asserted-by":"publisher","first-page":"117864691769193","DOI":"10.1177\/1178646917691938","volume":"10","author":"AA Badawy","year":"2017","unstructured":"Badawy AA (2017) Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects. Int J Tryptophan Res 10:1178646917691938. https:\/\/doi.org\/10.1177\/1178646917691938","journal-title":"Int J Tryptophan Res"},{"key":"1815_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.neubiorev.2020.08.010","volume":"118","author":"C Hunt","year":"2020","unstructured":"Hunt C et al (2020) Effect of immune activation on the kynurenine pathway and depression symptoms\u2014a systematic review and meta-analysis. Neurosci Biobehav Rev 118:514\u2013523. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.08.010","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"1815_CR8","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/s41598-020-58806-w","volume":"10","author":"M Sakurai","year":"2020","unstructured":"Sakurai M et al (2020) Serum metabolic profiles of the tryptophan-kynurenine pathway in the high risk subjects of major depressive disorder. Sci Rep 10(1):1961. https:\/\/doi.org\/10.1038\/s41598-020-58806-w","journal-title":"Sci Rep"},{"issue":"8","key":"1815_CR9","doi-asserted-by":"publisher","first-page":"949","DOI":"10.2174\/1381612822666151214104826","volume":"22","author":"L Dell\u2019Osso","year":"2016","unstructured":"Dell\u2019Osso L et al (2016) Depression, serotonin and tryptophan. Curr Pharm Des 22(8):949\u2013954. https:\/\/doi.org\/10.2174\/1381612822666151214104826","journal-title":"Curr Pharm Des"},{"key":"1815_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01661-0","author":"J Moncrieff","year":"2022","unstructured":"Moncrieff J et al (2022) The serotonin theory of depression: a systematic umbrella review of the evidence. Mol psychiatry. https:\/\/doi.org\/10.1038\/s41380-022-01661-0","journal-title":"Mol psychiatry"},{"key":"1815_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02092-1","author":"AF Almulla","year":"2023","unstructured":"Almulla AF, Maes M (2023) Although serotonin is not a major player in depression, its precursor is. Mol psychiatry. https:\/\/doi.org\/10.1038\/s41380-023-02092-1","journal-title":"Mol psychiatry"},{"key":"1815_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02094-z","author":"J Moncrieff","year":"2023","unstructured":"Moncrieff J et al (2023) The serotonin hypothesis of depression: both long discarded and still supported? Mol psychiatry. https:\/\/doi.org\/10.1038\/s41380-023-02094-z","journal-title":"Mol psychiatry"},{"key":"1815_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02090-3","author":"JPR Jacobsen","year":"2023","unstructured":"Jacobsen JPR (2023) Serotonin and depression-an alternative interpretation of the data in Moncrieff et al. Mol psychiatry. https:\/\/doi.org\/10.1038\/s41380-023-02090-3","journal-title":"Mol psychiatry"},{"issue":"1","key":"1815_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00406-022-01549-8","volume":"273","author":"HJ M\u00f6ller","year":"2023","unstructured":"M\u00f6ller HJ, Falkai P (2023) Is the serotonin hypothesis\/theory of depression still relevant? Methodological reflections motivated by a recently published umbrella review. Eur Arch Psychiatry Clin Neurosci 273(1):1\u20133. https:\/\/doi.org\/10.1007\/s00406-022-01549-8","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1815_CR15","doi-asserted-by":"publisher","first-page":"154148","DOI":"10.1016\/j.cyto.2017.09.004","volume":"122","author":"R Baumgartner","year":"2019","unstructured":"Baumgartner R, Forteza MJ, Ketelhuth DFJ (2019) The interplay between cytokines and the kynurenine pathway in inflammation and atherosclerosis. Cytokine 122:154148. https:\/\/doi.org\/10.1016\/j.cyto.2017.09.004","journal-title":"Cytokine"},{"issue":"23","key":"1815_CR16","doi-asserted-by":"publisher","first-page":"e2022447118","DOI":"10.1073\/pnas.2022447118","volume":"118","author":"S Klaessens","year":"2021","unstructured":"Klaessens S et al (2021) Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenase. Proc Natl Acad Sci U S A 118(23):e2022447118. https:\/\/doi.org\/10.1073\/pnas.2022447118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1815_CR17","doi-asserted-by":"publisher","first-page":"897929","DOI":"10.3389\/fmolb.2022.897929","volume":"9","author":"S Klaessens","year":"2022","unstructured":"Klaessens S et al (2022) Systemic tryptophan homeostasis. Front Mol Biosci 9:897929. https:\/\/doi.org\/10.3389\/fmolb.2022.897929","journal-title":"Front Mol Biosci"},{"issue":"3","key":"1815_CR18","doi-asserted-by":"publisher","first-page":"e23428","DOI":"10.4161\/onci.23428","volume":"2","author":"BC Creelan","year":"2013","unstructured":"Creelan BC et al (2013) Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in stage III non-small cell lung cancer. Oncoimmunology 2(3):e23428. https:\/\/doi.org\/10.4161\/onci.23428","journal-title":"Oncoimmunology"},{"issue":"12","key":"1815_CR19","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.7150\/jca.31727","volume":"10","author":"Z Ye","year":"2019","unstructured":"Ye Z et al (2019) Role of IDO and TDO in cancers and related diseases and the therapeutic implications. J Cancer 10(12):2771\u20132782. https:\/\/doi.org\/10.7150\/jca.31727","journal-title":"J Cancer"},{"key":"1815_CR20","unstructured":"Szab\u00f3 \u00c1 et al (2021) The tryptophan-kynurenine metabolic pathway. Scholarly community encyclopedia. https:\/\/encyclopedia.pub\/entry\/7774. Accessed 29 October 2023"},{"key":"1815_CR21","doi-asserted-by":"publisher","first-page":"101573","DOI":"10.1016\/j.arr.2022.101573","volume":"75","author":"A Salminen","year":"2022","unstructured":"Salminen A (2022) Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process. Ageing Res Rev 75:101573. https:\/\/doi.org\/10.1016\/j.arr.2022.101573","journal-title":"Ageing Res Rev"},{"key":"1815_CR22","doi-asserted-by":"publisher","unstructured":"Liang Y et al (2022) Kynurenine pathway metabolites as biomarkers in alzheimer\u2019s disease. Dis Markers 9484217. https:\/\/doi.org\/10.1155\/2022\/9484217","DOI":"10.1155\/2022\/9484217"},{"issue":"4","key":"1815_CR23","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/biomedicines10040849","volume":"10","author":"D Martos","year":"2022","unstructured":"Martos D et al (2022) Memory enhancement with kynurenic acid and its mechanisms in neurotransmission. Biomedicines 10(4):849. https:\/\/doi.org\/10.3390\/biomedicines10040849","journal-title":"Biomedicines"},{"issue":"16","key":"1815_CR24","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.3390\/cells11162607","volume":"11","author":"M Tanaka","year":"2022","unstructured":"Tanaka M et al (2022) Mitochondrial impairment: a common motif in neuropsychiatric presentation? The link to the tryptophan-kynurenine metabolic system. Cells 11(16):2607. https:\/\/doi.org\/10.3390\/cells11162607","journal-title":"Cells"},{"key":"1815_CR25","doi-asserted-by":"publisher","first-page":"646909","DOI":"10.1155\/2014\/646909","volume":"2014","author":"J Reyes Ocampo","year":"2014","unstructured":"Reyes Ocampo J et al (2014) Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases. Oxid Med Cell Longev 2014:646909. https:\/\/doi.org\/10.1155\/2014\/646909","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"1815_CR26","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3390\/cells10071603","volume":"10","author":"A Mor","year":"2021","unstructured":"Mor A et al (2021) Role of kynurenine pathway in oxidative stress during neurodegenerative disorders. Cells 10(7):1603. https:\/\/doi.org\/10.3390\/cells10071603","journal-title":"Cells"},{"issue":"3","key":"1815_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1515\/revneuro-2022-0047","volume":"34","author":"X Gong","year":"2022","unstructured":"Gong X et al (2022) The role and mechanism of tryptophan\u2014kynurenine metabolic pathway in depression. Rev Neurosci 34(3):313\u2013324. https:\/\/doi.org\/10.1515\/revneuro-2022-0047","journal-title":"Rev Neurosci"},{"key":"1815_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-981-19-7376-5_8","volume":"1411","author":"MED Mingoti","year":"2023","unstructured":"Mingoti MED et al (2023) Stress and kynurenine-inflammation pathway in major depressive disorder. Adv Exp Med Biol 1411:163\u2013190. https:\/\/doi.org\/10.1007\/978-981-19-7376-5_8","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"1815_CR29","doi-asserted-by":"publisher","first-page":"e13739","DOI":"10.1111\/ijcp.13739","volume":"75","author":"M \u00d6zt\u00fcrk","year":"2021","unstructured":"\u00d6zt\u00fcrk M et al (2021) The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder. Int J Clin Pract 75(4):e13739. https:\/\/doi.org\/10.1111\/ijcp.13739","journal-title":"Int J Clin Pract"},{"issue":"6","key":"1815_CR30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41386-020-0607-1","volume":"45","author":"E Haroon","year":"2020","unstructured":"Haroon E et al (2020) Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression. Neuropsychopharmacology 45(6):998\u20131007. https:\/\/doi.org\/10.1038\/s41386-020-0607-1","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"1815_CR31","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/15622975.2018.1468031","volume":"20","author":"A Messaoud","year":"2019","unstructured":"Messaoud A et al (2019) Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide. World J Biol Psychiatry 20(9):703\u2013711. https:\/\/doi.org\/10.1080\/15622975.2018.1468031","journal-title":"World J Biol Psychiatry"},{"issue":"6","key":"1815_CR32","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.bbi.2011.05.002","volume":"25","author":"ME Sublette","year":"2011","unstructured":"Sublette ME et al (2011) Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain Behav Immun 25(6):1272\u20131278. https:\/\/doi.org\/10.1016\/j.bbi.2011.05.002","journal-title":"Brain Behav Immun"},{"issue":"1","key":"1815_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000491604","volume":"77","author":"M Pompili","year":"2018","unstructured":"Pompili M et al (2018) Tryptophan and kynurenine metabolites: are they related to depression? Neuropsychobiology 77(1):23\u201328. https:\/\/doi.org\/10.1159\/000491604","journal-title":"Neuropsychobiology"},{"issue":"10","key":"1815_CR34","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.3390\/nu12103183","volume":"12","author":"C Chojnacki","year":"2020","unstructured":"Chojnacki C et al (2020) Tryptophan intake and metabolism in older adults with mood disorders. Nutrients 12(10):3183. https:\/\/doi.org\/10.3390\/nu12103183","journal-title":"Nutrients"},{"issue":"4","key":"1815_CR35","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/nu15040847","volume":"15","author":"C Chojnacki","year":"2023","unstructured":"Chojnacki C et al (2023) Beneficial effect of increased tryptophan intake on its metabolism and mental state of the elderly. Nutrients 15(4):847. https:\/\/doi.org\/10.3390\/nu15040847","journal-title":"Nutrients"},{"key":"1815_CR36","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fpsyt.2020.00338","volume":"11","author":"Y Wu","year":"2020","unstructured":"Wu Y et al (2020) Changes of altruistic behavior and kynurenine pathway in late-life depression. Front Psychiatry 11:338. https:\/\/doi.org\/10.3389\/fpsyt.2020.00338","journal-title":"Front Psychiatry"},{"issue":"8","key":"1815_CR37","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1038\/s41380-019-0589-8","volume":"26","author":"B Kadriu","year":"2021","unstructured":"Kadriu B et al (2021) The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response. Mol Psychiatry 26(8):4085\u20134095. https:\/\/doi.org\/10.1038\/s41380-019-0589-8","journal-title":"Mol Psychiatry"},{"issue":"6","key":"1815_CR38","doi-asserted-by":"publisher","first-page":"6010","DOI":"10.3390\/ijms24066010","volume":"24","author":"ML Pais","year":"2023","unstructured":"Pais ML et al (2023) Sex differences in tryptophan metabolism: a systematic review focused on neuropsychiatric disorders. Int J Mol Sci 24(6):6010. https:\/\/doi.org\/10.3390\/ijms24066010","journal-title":"Int J Mol Sci"},{"key":"1815_CR39","doi-asserted-by":"publisher","first-page":"117864691986897","DOI":"10.1177\/1178646919868978","volume":"12","author":"AA Badawy","year":"2019","unstructured":"Badawy AA, Guillemin G (2019) The plasma [kynurenine]\/[tryptophan] ratio and indoleamine 2,3-dioxygenase: time for appraisal. Int J Tryptophan Res 12:1178646919868978. https:\/\/doi.org\/10.1177\/1178646919868978","journal-title":"Int J Tryptophan Res"},{"key":"1815_CR40","unstructured":"World Health Organization (n.d.) (1992) The ICD-10 classification of mental and behavioural disorders\u202f: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva. https:\/\/apps.who.int\/iris\/handle\/10665\/37958"},{"issue":"1","key":"1815_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s12264-011-1035-3","volume":"25","author":"YX Liu","year":"2011","unstructured":"Liu YX, Liu J, Wang YF (2011) Reliability and validity of Chinese version of the mini international neuropsychiatric interview for children and adolescents (child version). Chin Ment Health J 25(1):8\u201313. https:\/\/doi.org\/10.1007\/s12264-011-1035-3","journal-title":"Chin Ment Health J"},{"key":"1815_CR42","doi-asserted-by":"publisher","unstructured":"Morelen DM (2017) Children\u2019s depression inventory-2 BT. In: Zeigler-Hill V, Shackelford TK (eds) Encyclopedia of personality and individual differences. Springer International Publishing, Cham, pp 1\u20135. https:\/\/doi.org\/10.1007\/978-3-319-28099-8_16-1","DOI":"10.1007\/978-3-319-28099-8_16-1"},{"issue":"1","key":"1815_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4306\/pi.2015.12.1.23","volume":"12","author":"YR Bang","year":"2015","unstructured":"Bang YR, Park JH, Kim SH (2015) Cut-off scores of the children\u2019s depression inventory for screening and rating severity in korean adolescents. Psychiatry Investig 12(1):23\u201328. https:\/\/doi.org\/10.4306\/pi.2015.12.1.23","journal-title":"Psychiatry Investig"},{"issue":"3","key":"1815_CR44","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10578-018-0854-0","volume":"50","author":"B Behrens","year":"2019","unstructured":"Behrens B et al (2019) The screen for child anxiety related emotional disorders (SCARED): informant discrepancy, measurement invariance, and test-retest reliability. Child Psychiatry Hum Dev 50(3):473\u2013482. https:\/\/doi.org\/10.1007\/s10578-018-0854-0","journal-title":"Child Psychiatry Hum Dev"},{"issue":"4","key":"1815_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.5498\/wjp.v13.i4.141","volume":"13","author":"AA Badawy","year":"2023","unstructured":"Badawy AA, Dawood S, Bano S (2023) Kynurenine pathway of tryptophan metabolism in pathophysiology and therapy of major depressive disorder. World J Psychiatry 13(4):141\u2013148. https:\/\/doi.org\/10.5498\/wjp.v13.i4.141","journal-title":"World J Psychiatry"},{"key":"1815_CR46","doi-asserted-by":"publisher","first-page":"102461","DOI":"10.1016\/j.ctrv.2022.102461","volume":"110","author":"Y Fujiwara","year":"2022","unstructured":"Fujiwara Y et al (2022) Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy. Cancer Treat Rev 110:102461. https:\/\/doi.org\/10.1016\/j.ctrv.2022.102461","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"1815_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13287-020-02118-3","volume":"12","author":"S Zhang","year":"2021","unstructured":"Zhang S et al (2021) Inflammatory cytokines-stimulated human muscle stem cells ameliorate ulcerative colitis via the IDO-TSG6 axis. Stem Cell Res Ther 12(1):50. https:\/\/doi.org\/10.1186\/s13287-020-02118-3","journal-title":"Stem Cell Res Ther"},{"key":"1815_CR48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","volume":"90","author":"K Ogyu","year":"2018","unstructured":"Ogyu K et al (2018) Kynurenine pathway in depression: a systematic review and meta-analysis. Neurosci Biobehav Rev 90:16\u201325. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.03.023","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"1815_CR49","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s11011-018-0290-7","volume":"33","author":"Y Qin","year":"2018","unstructured":"Qin Y et al (2018) IDO and TDO as a potential therapeutic target in different types of depression. Metab Brain Dis 33(6):1787\u20131800. https:\/\/doi.org\/10.1007\/s11011-018-0290-7. (Epub 2018 Jul 16)","journal-title":"Metab Brain Dis"},{"issue":"8","key":"1815_CR50","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.clinbiochem.2004.02.007","volume":"37","author":"B Frick","year":"2004","unstructured":"Frick B et al (2004) Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. Clin Biochem 37(8):684\u2013687. https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.02.007","journal-title":"Clin Biochem"},{"key":"1815_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.psyneuen.2015.02.011","volume":"56","author":"J Dahl","year":"2015","unstructured":"Dahl J et al (2015) Ongoing episode of major depressive disorder is not associated with elevated serum levels of kynurenine pathway markers. Psychoneuroendocrinology 56:12\u201322. https:\/\/doi.org\/10.1016\/j.psyneuen.2015.02.011","journal-title":"Psychoneuroendocrinology"},{"key":"1815_CR52","doi-asserted-by":"publisher","first-page":"100537","DOI":"10.1016\/j.bbih.2022.100537","volume":"26","author":"AF Almulla","year":"2022","unstructured":"Almulla AF et al (2022) The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: a systematic review and meta-analysis. Brain Behav Immun Health 26:100537. https:\/\/doi.org\/10.1016\/j.bbih.2022.100537","journal-title":"Brain Behav Immun Health"},{"issue":"12","key":"1815_CR53","doi-asserted-by":"publisher","first-page":"7328","DOI":"10.1038\/s41380-021-01269-w","volume":"26","author":"J Pu","year":"2021","unstructured":"Pu J et al (2021) Metabolomic changes in animal models of depression: a systematic analysis. Mol Psychiatry 26(12):7328\u20137336. https:\/\/doi.org\/10.1038\/s41380-021-01269-w. (Epub 2021 Sep 1)","journal-title":"Mol Psychiatry"},{"key":"1815_CR54","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fncel.2015.00268","volume":"9","author":"WK Jo","year":"2015","unstructured":"Jo WK et al (2015) Glia in the cytokine-mediated onset of depression: fine tuning the immune response. Front Cell Neurosci 9:268. https:\/\/doi.org\/10.3389\/fncel.2015.00268","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"1815_CR55","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/08039488.2021.1992647","volume":"76","author":"W Ding","year":"2022","unstructured":"Ding W et al (2022) Increased plasma level of kynurenic acid in drug-free patients with first-episode schizophrenia compared to patients with chronic schizophrenia and healthy controls: preliminary data. Nord J Psychiatry 76(6):451\u2013456. https:\/\/doi.org\/10.1080\/08039488.2021.1992647","journal-title":"Nord J Psychiatry"},{"key":"1815_CR56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.bbi.2021.10.020","volume":"99","author":"MI Butler","year":"2022","unstructured":"Butler MI et al (2022) The immune-kynurenine pathway in social anxiety disorder. Brain Behav Immun 99:317\u2013326. https:\/\/doi.org\/10.1016\/j.bbi.2021.10.020","journal-title":"Brain Behav Immun"},{"issue":"4","key":"1815_CR57","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00281-021-00867-8","volume":"43","author":"A Carambia","year":"2021","unstructured":"Carambia A, Schuran FA (2021) The aryl hydrocarbon receptor in liver inflammation. Semin Immunopathol 43(4):563\u2013575. https:\/\/doi.org\/10.1007\/s00281-021-00867-8","journal-title":"Semin Immunopathol"},{"key":"1815_CR58","doi-asserted-by":"crossref","unstructured":"Dawood S, Bano S, Badawy AA (2022) Inflammation and serotonin deficiency in major depressive disorder: molecular docking of antidepressant and anti-inflammatory drugs to tryptophan and indoleamine 2,3-dioxygenases. Biosci Rep 42(5):BSR20220426. 10.1042\/BSR20220426","DOI":"10.1042\/BSR20220426"},{"key":"1815_CR59","doi-asserted-by":"publisher","first-page":"117864692211225","DOI":"10.1177\/11786469221122511","volume":"15","author":"AA Badawy","year":"2022","unstructured":"Badawy AA, Guillemin GJ (2022) Species differences in tryptophan metabolism and disposition. Int J Tryptophan Res 15:11786469221122512. https:\/\/doi.org\/10.1177\/11786469221122511","journal-title":"Int J Tryptophan Res"},{"issue":"8","key":"1815_CR60","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s00702-023-02648-z","volume":"130","author":"KA Jellinger","year":"2023","unstructured":"Jellinger KA (2023) The heterogeneity of late-life depression and its pathobiology: a brain network dysfunction disorder. J Neural Transm 130(8):1057\u20131076. https:\/\/doi.org\/10.1007\/s00702-023-02648-z","journal-title":"J Neural Transm"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-024-01815-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-024-01815-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-024-01815-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T05:18:55Z","timestamp":1749446335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-024-01815-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1815"],"URL":"https:\/\/doi.org\/10.1007\/s00406-024-01815-x","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]},"assertion":[{"value":"28 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our study was conducted at the Shanghai East Hospital Affiliated Tongji University and received ethical approval from the institutional review board and ethics committee of the hospital. The present investigation was carried out in accordance with the latest version of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Chuanyuan Kang and Lieying Fan designed the study. Zhihan Ye and Shuran Yang determined the samples and completed the statistical analysis. Liu Lu and Ming Zong completed the collection and investigation of clinical data. Zhihan Ye and Shuran Yang wrote the first draft of the manuscript. Chuanyuan Kang and Lieying Fan diligently revised and edited the manuscript draft. All authors approved the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author statement"}}]}}